The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer

Conclusion: IBC patients with Ki-67-positive tumors tended to have worse overall survival, but were more likely to benefit from trimodality treatment, with better overall survival and distant metastasis-free survival. Patients with Ki-67-negative tumors had similar survival distributions, regardless of whether they received trimodality treatment.

Source: Journal of Cancer - June 13, 2019 Category: Cancer & Oncology Authors: Jing Ning, Tamer M Fouad, Heather Lin, Aysegul A Sahin, Anthony Lucci, Wendy A. Woodward, Savitri Krishnamurthy, Debu Tripathy, Naoto T. Ueno, Yu Shen Tags: Research Paper Source Type: research